Diaper Need Met Among Low-Income US Children Younger Than 4 Years in 2016

Kelley E C Massengale1, Lynn H Comer1, Anna E Austin1

  • 1Kelley E. C. Massengale, Lynn H. Comer, and Joanne S. Goldblum are with the National Diaper Bank Network, New Haven CT. Anna E. Austin is with the University of North Carolina at Chapel Hill.

Insights

Diaper banks assist few low-income families with diaper needs. This study found that 0% to 16% of children facing diaper insecurity received help monthly from these essential community resources.

Area of Science:

  • Public Health
  • Social Determinants of Health
  • Poverty and Child Welfare

Background:

  • Diaper insecurity affects a significant number of low-income families in the United States.
  • Access to diapers is crucial for infant and child health and well-being.
  • Existing community-based safety nets, like diaper banks, aim to address this need.

Purpose of the Study:

  • To document the collective efforts of diaper banks nationwide.
  • To estimate the proportion of diaper needs met for low-income children.
  • To assess the reach of the diaper bank network in the US.

Main Methods:

  • A survey was conducted with 262 diaper banks across the US between January and March 2017.
  • Data on 2016 activities were collected from participating diaper banks.
  • State-level analysis compared the number of children under 4 in families below 200% federal poverty level with those served by diaper banks.

Main Results:

  • The percentage of children experiencing diaper need who received assistance from a diaper bank varied by state, ranging from 0% to 16% monthly.
  • A small proportion of eligible children accessed diapers through this network.
  • Significant gaps exist in meeting the diaper needs of low-income families.

Conclusions:

  • The study concludes that the current network of nonprofit diaper banks meets only a small fraction of the diaper needs of low-income families.
  • The findings underscore the limited reach of the existing community-based safety net for diaper insecurity.
  • Federal, state, and municipal policies are recommended to address this consequence of poverty.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
218
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
215
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
547